Literature DB >> 27797905

Is Change in Albuminuria a Surrogate Marker for Cardiovascular and Renal Outcomes in Type 1 Diabetes?

Bradley S Dixon1,2.   

Abstract

Entities:  

Keywords:  Biomarkers; Cardiovascular System; Diabetes Mellitus; Epidemiology and outcomes; Type 1; albuminuria; cardiovascular disease; diabetes mellitus; diabetic nephropathy; kidney; microalbuminuria

Mesh：

Substances：

Year:  2016        PMID： 27797905      PMCID： PMC5108209          DOI： 10.2215/CJN.09540916

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  23 in total

Review 1.  Diabetic kidney disease with and without albuminuria.

Authors:  Richard J Macisaac; George Jerums
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

2.  The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels.

Authors:  H Keen; C Chlouverakis; J Fuller; R J Jarrett
Journal:  Guys Hosp Rep       Date:  1969

3.  Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.

Authors:  H H Parving; B Oxenbøll; P A Svendsen; J S Christiansen; A R Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1982-08

Review 4.  Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis.

Authors:  Hiddo J Lambers Heerspink; Tobias F Kröpelin; Jarno Hoekman; Dick de Zeeuw
Journal:  J Am Soc Nephrol       Date:  2014-11-24       Impact factor: 10.121

Review 5.  Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View.

Authors:  Linda F Fried; Julia Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

6.  Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Authors:  Folkert W Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick de Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

Review 7.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

8.  Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes.

Authors:  Shin-ichi Araki; Masakazu Haneda; Daisuke Koya; Hideki Hidaka; Toshiro Sugimoto; Motohide Isono; Keiji Isshiki; Masami Chin-Kanasaki; Takashi Uzu; Atsunori Kashiwagi
Journal:  Diabetes       Date:  2007-03-14       Impact factor: 9.461

9.  initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial.

Authors:  Merel E Hellemons; Frederik Persson; Stephan J L Bakker; Peter Rossing; Hans-Henrik Parving; Dick De Zeeuw; Hiddo J Lambers Heerspink
Journal:  Diabetes Care       Date:  2011-07-25       Impact factor: 19.112

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Authors:  Caroline S Fox; Kunihiro Matsushita; Mark Woodward; Henk J G Bilo; John Chalmers; Hiddo J Lambers Heerspink; Brian J Lee; Robert M Perkins; Peter Rossing; Toshimi Sairenchi; Marcello Tonelli; Joseph A Vassalotti; Kazumasa Yamagishi; Josef Coresh; Paul E de Jong; Chi-Pang Wen; Robert G Nelson
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321
View more
  2 in total

1.  Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate.

Authors:  Amanda Leong; Elif Ilhan Ekinci; Cattram Nguyen; Michele Milne; Mariam Hachem; Matthew Dobson; Richard J MacIsaac; George Jerums
Journal:  BMC Nephrol       Date:  2017-12-06       Impact factor: 2.388

Review 2.  Assessing Cardiovascular Risk in Patients with Diabetes: An Update.

Authors:  Christos Damaskos; Nikolaos Garmpis; Paraskevi Kollia; Georgios Mitsiopoulos; Danai Barlampa; Athanasios Drosos; Alexandros Patsouras; Nikolaos Gravvanis; Vasileios Antoniou; Alexandros Litos; Evangelos Diamantis
Journal:  Curr Cardiol Rev       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.